| adrenergic receptor, alpha 2a |
EBASTINE |
Adrenergic alpha2A |
97% |
.8316uM |
.3119uM |
View
|
| opioid receptor, sigma 1 |
PRAMOXINE |
Sigma1 |
97% |
.121uM |
.051uM |
View
|
| monoamine oxidase A |
RESVERATROL |
Monoamine Oxidase MAOA |
97% |
.449uM |
NoneNone |
View
|
| monoamine oxidase A |
RESVERATROL |
Monoamine Oxidase MAOA |
97% |
.449uM |
NoneNone |
View
|
| tachykinin receptor 2 |
BENZETHONIUM CHLORIDE |
Tachykinin NK2 |
97% |
1.925uM |
.642uM |
View
|
| cholinergic receptor, muscarinic 3 |
BENZETHONIUM CHLORIDE |
Muscarinic M3 |
97% |
.383uM |
.081uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
CLOBETASOL PROPIONATE |
Glucocorticoid |
97% |
.001456uM |
.000662uM |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
CADMIUM ACETATE |
Protein Tyrosine Kinase, Lck |
97% |
.824uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
YOHIMBINE |
Adrenergic alpha2C |
97% |
.036uM |
.005162uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
YOHIMBINE |
Adrenergic alpha2C |
97% |
.036uM |
.005162uM |
View
|
| adrenergic receptor, alpha 2a |
DIHYDROERGOTAMINE |
Adrenergic alpha2A |
97% |
.001032uM |
.000387uM |
View
|
| adrenergic receptor, alpha 2b |
DIHYDROERGOTAMINE |
Adrenergic alpha2C |
97% |
.01uM |
.00151uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
DIHYDROERGOTAMINE |
Adrenergic alpha2C |
97% |
.01uM |
.00151uM |
View
|
| dopamine receptor 2 |
TAMOXIFEN |
Dopamine D2L |
97% |
13.885uM |
4.628uM |
View
|
| adrenergic receptor, alpha 2a |
BRIMONIDINE |
Adrenergic alpha2A |
97% |
.298uM |
.112uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
DICYCLOMINE |
Serotonin 5-HT2C |
97% |
.468uM |
.245uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
DIFLORASONE DIACETATE |
Glucocorticoid |
97% |
.006396uM |
.002907uM |
View
|
| monoamine oxidase A |
TETRACAINE |
Monoamine Oxidase MAOA |
97% |
.317uM |
NoneNone |
View
|
| monoamine oxidase A |
TETRACAINE |
Monoamine Oxidase MAOA |
97% |
.317uM |
NoneNone |
View
|
| progesterone receptor |
FLUOCINOLONE ACETONIDE |
Progesterone |
97% |
.026uM |
.003346uM |
View
|
| progesterone receptor |
FLUOCINOLONE ACETONIDE |
Progesterone |
97% |
.026uM |
.003346uM |
View
|
| androgen receptor |
CHLORMADINONE ACETATE |
Testosterone |
97% |
.0313uM |
.0209uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
CARVEDILOL |
Serotonin 5-HT2B |
97% |
.023uM |
.015uM |
View
|
| dopamine receptor D3 |
CLOZAPINE |
Dopamine D3 |
97% |
.258uM |
.088uM |
View
|
| dopamine receptor D1A |
CLOZAPINE |
Dopamine D1 |
97% |
.107uM |
.053uM |
View
|
| dopamine receptor D1A |
FLUPHENAZINE |
Dopamine D1 |
97% |
.023uM |
.011uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
FLUOXETINE |
Serotonin 5-HT2C |
97% |
.119uM |
.062uM |
View
|
| cholinergic receptor, muscarinic 1 |
DOXEPIN |
Muscarinic M1 |
97% |
.077uM |
.018uM |
View
|
| cholinergic receptor, muscarinic 3 |
DOXEPIN |
Muscarinic M3 |
97% |
.069uM |
.015uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DOXEPIN |
Adrenergic, Norepinephrine Transporter |
97% |
.029uM |
.029uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
DOXEPIN |
Serotonin 5-HT2C |
97% |
.046uM |
.024uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
DICUMAROL |
CYP450-2C9 Inhibition |
97% |
.3uM |
NoneNone |
View
|
| protein kinase C, alpha |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
DICUMAROL |
CYP450-2C9 Inhibition |
97% |
.3uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
TRAZODONE |
Serotonin 5-HT1A |
97% |
.311uM |
.178uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
TRAZODONE |
Serotonin Transporter |
97% |
.192uM |
.102uM |
View
|
| adrenergic receptor, beta 1 |
LEVOBUNOLOL |
Adrenergic beta1 |
97% |
.0069uM |
.003985uM |
View
|
| adrenergic, beta-1-, receptor |
LEVOBUNOLOL |
Adrenergic beta1 |
97% |
.0069uM |
.003985uM |
View
|
| adrenergic receptor, alpha 2a |
GENTIAN VIOLET |
Adrenergic alpha2A |
97% |
.536uM |
.201uM |
View
|
| cholinergic receptor, muscarinic 4 |
GENTIAN VIOLET |
Muscarinic M4 |
97% |
1.005uM |
.14uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
VERAPAMIL |
Serotonin Transporter |
97% |
.24uM |
.127uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
BROMOCRIPTINE |
Serotonin 5-HT1B |
97% |
.103uM |
.047uM |
View
|
| adrenergic receptor, alpha 2b |
GUANFACINE |
Adrenergic alpha2B |
97% |
.249uM |
.114uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLIPIZIDE |
Potassium Channel [KATP] |
97% |
.398uM |
.045uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
GLIPIZIDE |
Potassium Channel [KATP] |
97% |
.398uM |
.045uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLIPIZIDE |
Potassium Channel [KATP] |
97% |
.398uM |
.045uM |
View
|
| A3 adenosine receptor |
FELODIPINE |
Adenosine A3 |
97% |
1.057uM |
.597uM |
View
|
| adrenergic receptor, alpha 1a |
MIANSERIN |
Adrenergic alpha1A |
97% |
.224uM |
.091uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
MIANSERIN |
Serotonin 5-HT2B |
97% |
.007295uM |
.004642uM |
View
|
| adrenergic receptor, beta 2 |
ISOPRENALINE |
Adrenergic beta2 |
97% |
.246uM |
.169uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
LYSERGOL |
Serotonin 5-HT1A |
97% |
.007831uM |
.004475uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
MEPAZINE |
Adrenergic alpha1D |
97% |
.137uM |
.067uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
MITOTANE |
Dopamine Transporter |
97% |
1.001uM |
.795uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
DIELDRIN |
GABAA, Chloride Channel, TBOB |
97% |
.335uM |
.3uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
PROPRANOLOL |
Serotonin 5-HT1A |
97% |
.243uM |
.139uM |
View
|
| dopamine receptor 2 |
RISPERIDONE |
Dopamine D2L |
97% |
.02uM |
.006545uM |
View
|
| histamine receptor H 1 |
KETOTIFEN |
Histamine H1, Central |
97% |
.001188uM |
.000138uM |
View
|
| adrenergic, beta-1-, receptor |
BOPINDOLOL |
Adrenergic beta1 |
97% |
.047uM |
.027uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
SERTRALINE |
Sodium Channel, Site 2 |
97% |
2.5615uM |
2.3368uM |
View
|
| sodium channel associated protein 1 |
SERTRALINE |
Sodium Channel, Site 2 |
97% |
2.5615uM |
2.3368uM |
View
|
| adrenergic receptor, alpha 1a |
CYPROHEPTADINE |
Adrenergic alpha1A |
97% |
.241uM |
.098uM |
View
|
| adrenergic receptor, alpha 2a |
PIPAMAZINE |
Adrenergic alpha2A |
97% |
.066uM |
.025uM |
View
|
| adrenergic receptor, beta 2 |
S-(-)-PROPRANOLOL |
Adrenergic beta2 |
97% |
.000355uM |
.000244uM |
View
|
| histamine receptor H 1 |
PIPAMAZINE |
Histamine H1, Central |
97% |
.009939uM |
.001154uM |
View
|
| cholinergic receptor, muscarinic 2 |
HOMATROPINE HYDROBROMIDE |
Muscarinic M2 |
97% |
.212uM |
.075uM |
View
|
| protein kinase C, delta |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
MICONAZOLE |
Serotonin 5-HT1A |
97% |
11.472uM |
6.555uM |
View
|
| A3 adenosine receptor |
ECONAZOLE |
Adenosine A3 |
97% |
3.249uM |
1.836uM |
View
|
| adrenergic receptor, beta 3 |
ECONAZOLE |
Adrenergic beta3 |
97% |
6.15uM |
4.612uM |
View
|
| 5-hydroxytryptamine receptor 6 |
ECONAZOLE |
Serotonin 5-HT6 |
97% |
10.899uM |
5.06uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
ECONAZOLE |
Serotonin Transporter |
97% |
.423uM |
.225uM |
View
|
| cholinergic receptor, muscarinic 1 |
MICONAZOLE |
Muscarinic M1 |
97% |
3.971uM |
.956uM |
View
|
| adenosine A2a receptor |
MICONAZOLE |
Adenosine A2A |
97% |
14.253uM |
8.002uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
KETOCONAZOLE |
CYP450-3A4 Inhibition |
97% |
.016uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
DEXCHLORPHENIRAMINE |
Muscarinic M5 |
97% |
1.043uM |
.749uM |
View
|
| adrenergic receptor, alpha 2b |
ERGOCORNINE |
Adrenergic alpha2C |
97% |
.017uM |
.002409uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
ERGOCORNINE |
Adrenergic alpha2C |
97% |
.017uM |
.002409uM |
View
|
| dopamine receptor 2 |
ERGOCORNINE |
Dopamine D2L |
97% |
.005032uM |
.001677uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
SULCONAZOLE |
CYP450-2C9 Inhibition |
97% |
.2uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
SULCONAZOLE |
CYP450-2C9 Inhibition |
97% |
.2uM |
NoneNone |
View
|
| progesterone receptor |
MIFEPRISTONE |
Progesterone |
97% |
.003245uM |
.000423uM |
View
|
| progesterone receptor |
MIFEPRISTONE |
Progesterone |
97% |
.003245uM |
.000423uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
ETHINYLESTRADIOL |
Serotonin Transporter |
97% |
.054uM |
.029uM |
View
|
| cathepsin G |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protease, Cathepsin G |
97% |
.8519uM |
NoneNone |
View
|
| mast cell protease 9 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protease, Cathepsin G |
97% |
.8519uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
MESTRANOL |
Serotonin Transporter |
97% |
.041uM |
.022uM |
View
|
| androgen receptor |
PROGESTERONE |
Testosterone |
97% |
.214uM |
.143uM |
View
|
| androgen receptor |
BETA-ESTRADIOL 3-BENZOATE |
Testosterone |
97% |
.01uM |
.006981uM |
View
|
| mitogen activated protein kinase 3 |
TIRILAZAD |
Protein Serine/Threonine Kinase, ERK1 |
97% |
16.262uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
TIRILAZAD |
Protein Serine/Threonine Kinase, ERK1 |
97% |
16.262uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| arachidonate 15-lipoxygenase |
O-ANISIDINE |
Lipoxygenase 15-LO |
97% |
2.048uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase, second type |
O-ANISIDINE |
Lipoxygenase 15-LO |
97% |
2.048uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
O-ANISIDINE |
Lipoxygenase 15-LO |
97% |
2.048uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
LISURIDE |
Adrenergic alpha2C |
97% |
.004308uM |
.000626uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
LISURIDE |
Adrenergic alpha2C |
97% |
.004308uM |
.000626uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PROMAZINE |
Serotonin 5-HT2C |
97% |
.099uM |
.052uM |
View
|
| Protein-tyrosine kinase, Fyn |
NELFINAVIR |
Protein Tyrosine Kinase, Fyn |
97% |
7.971uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
TERCONAZOLE |
Adrenergic alpha2C |
97% |
.418uM |
.061uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
TERCONAZOLE |
Adrenergic alpha2C |
97% |
.418uM |
.061uM |
View
|
| adrenergic receptor, alpha 2b |
TERCONAZOLE |
Adrenergic alpha2B |
97% |
2.729uM |
1.246uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| protein kinase D1 |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PAROXETINE |
Calcium Channel Type L, Benzothiazepine |
97% |
.373uM |
.331uM |
View
|
| adrenergic receptor, alpha 2b |
METERGOLINE |
Adrenergic alpha2C |
97% |
.189uM |
.027uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
METERGOLINE |
Adrenergic alpha2C |
97% |
.189uM |
.027uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
METERGOLINE |
Serotonin 5-HT2C |
97% |
.000663uM |
.000347uM |
View
|
| dopamine receptor 2 |
PERGOLIDE |
Dopamine D2L |
97% |
.111uM |
.037uM |
View
|
| cholinergic receptor, muscarinic 5 |
PROCHLORPERAZINE |
Muscarinic M5 |
97% |
.22uM |
.158uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PROCHLORPERAZINE |
Serotonin 5-HT2C |
97% |
.078uM |
.041uM |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 5 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 3 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CISAPRIDE |
Potassium Channel HERG |
97% |
.1701uM |
.1394uM |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
BENZETHONIUM CHLORIDE |
Potassium Channel HERG |
97% |
.1085uM |
.0889uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
BENZETHONIUM CHLORIDE |
Potassium Channel HERG |
97% |
.1085uM |
.0889uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
BENZETHONIUM CHLORIDE |
Potassium Channel HERG |
97% |
.1085uM |
.0889uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
BENZETHONIUM CHLORIDE |
Potassium Channel HERG |
97% |
.1085uM |
.0889uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMLODIPINE |
Calcium Channel Type L, Dihydropyridine |
97% |
.031uM |
.02uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
AMOXAPINE |
Serotonin 5-HT2B |
97% |
.01uM |
.006569uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
AMOXAPINE |
Serotonin 5-HT3 |
97% |
1.199uM |
.269uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
AMOXAPINE |
Serotonin 5-HT3 |
97% |
1.199uM |
.269uM |
View
|
| adrenergic receptor, alpha 2b |
FLUNARIZINE |
Adrenergic alpha2C |
97% |
.222uM |
.032uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
FLUNARIZINE |
Adrenergic alpha2C |
97% |
.222uM |
.032uM |
View
|
| phosphodiesterase 4A, cAMP specific |
TANNIC ACID |
Phosphodiesterase PDE4 |
97% |
1.043uM |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
TANNIC ACID |
Phosphodiesterase PDE4 |
97% |
1.043uM |
NoneNone |
View
|
| phosphodiesterase 4D |
TANNIC ACID |
Phosphodiesterase PDE4 |
97% |
1.043uM |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
TANNIC ACID |
Phosphodiesterase PDE4 |
97% |
1.043uM |
NoneNone |
View
|
| dopamine receptor 2 |
AMOXAPINE |
Dopamine D2L |
97% |
.2uM |
.067uM |
View
|
| dopamine receptor D4 |
CLOTRIMAZOLE |
Dopamine D4.2 |
97% |
19.919uM |
6.985uM |
View
|
| adrenergic receptor, alpha 2a |
CLOTRIMAZOLE |
Adrenergic alpha2A |
97% |
11.886uM |
4.457uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CLOTRIMAZOLE |
Serotonin Transporter |
97% |
5.76uM |
3.06uM |
View
|
| cholinergic receptor, muscarinic 2 |
CLOTRIMAZOLE |
Muscarinic M2 |
97% |
14.531uM |
5.167uM |
View
|
| cholinergic receptor, muscarinic 2 |
CHLORPROMAZINE |
Muscarinic M2 |
97% |
.652uM |
.232uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
OXICONAZOLE |
CYP450-3A4 Inhibition |
97% |
.09uM |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
PODOPHYLLOTOXIN |
CYP450-3A4 Inhibition |
97% |
.6uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
PHENELZINE |
CYP450-2D6 Inhibition |
97% |
1uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
METERGOLINE |
CYP450-2D6 Inhibition |
97% |
.2uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
METHYLERGONOVINE |
CYP450-2D6 Inhibition |
97% |
.2uM |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
LACIDIPINE |
CYP450-2C9 Inhibition |
97% |
2uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
LACIDIPINE |
CYP450-2C9 Inhibition |
97% |
2uM |
NoneNone |
View
|
| A3 adenosine receptor |
4-NONYLPHENOL |
Adenosine A3 |
97% |
1.915uM |
1.082uM |
View
|
| dopamine receptor 2 |
ALPHA-ERGOCRYPTINE |
Dopamine D2L |
97% |
.00195uM |
.00065uM |
View
|
| Protein-tyrosine kinase, Fyn |
LEAD(IV) ACETATE |
Protein Tyrosine Kinase, Fyn |
97% |
3.305uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
ALPHA-ERGOCRYPTINE |
Adrenergic alpha2C |
97% |
.038uM |
.005484uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
ALPHA-ERGOCRYPTINE |
Adrenergic alpha2C |
97% |
.038uM |
.005484uM |
View
|
